Search Results: PARP inhibitor

Experts call for breast cancer trials aimed at younger patients

A lack of clinical trials aimed specifically at younger breast cancer patients could be partly to blame for their poorer survival rates. A lack of clinical trials aimed specifically at younger breast cancer patients could be partly to blame for their poorer survival rates.

31 May 2013

• Science & Technology
• Health & Medicine

Joining the dots - how lab research can lead to new approaches for treating cancer

26 May 2013

• Science & Technology
• Health & Medicine

Angelina Jolie, inherited breast cancer and the BRCA1 gene

Celebrity cancer stories often hit the headlines - we answer some key questions following recent reports of genetic risks for breast cancer. Celebrity cancer stories often hit the headlines - we answer some key questions following recent reports of genetic risks for breast cancer.

14 May 2013

• Health & Medicine

2012 - A year of progress

17 December 2012

• Science & Technology
• Health & Medicine

Notes from NCRI conference (day 4)

7 November 2012

• Science & Technology
• Health & Medicine

News digest – bowel cancer news, HPV and cervical cancer, diesel fumes and dental hygiene

16 June 2012

• Health & Medicine
• Science & Technology

News digest – brain imaging, eye cancer, processed meat and more

14 January 2012

Cancer Research UK launches 'outpatients' trial of breast and ovarian cancer drug

Cancer Research UK's Drug Development Office has re-launched a trial of a promising drug to treat inherited breast and ovarian cancer - but this time taken as a tablet by outpatients. Cancer Research UK's Drug Development Office has re-launched a trial of a promising drug to treat inherited breast and ovarian cancer - but this time taken as a tablet by outpatients.

11 January 2012

• Policy & Insight
• Science & Technology

Expert Opinion: Professor Fran Balkwill

16 November 2011

First evidence of new 'druggable' DNA repair target to destroy cancer cells

BLOCKING a key DNA damage repair enzyme, called APE1, could provide a new way to kill cancer cells containing faulty BRCA genes. BLOCKING a key DNA damage repair enzyme, called APE1, could provide a new way to kill cancer cells containing faulty BRCA genes.

7 November 2011

Gene testing young prostate cancer patients could help target treatment

ROUTINELY testing for a faulty BRCA2 gene in under-65s with prostate cancer could help identify men who could benefit from new types of targeted treatment, new research published in the British Journal of Cancer* today shows. ROUTINELY testing for a faulty BRCA2 gene in under-65s with prostate cancer could help identify men who could benefit from new types of targeted treatment, new research published in the British Journal of Cancer* today shows.

12 October 2011